DNM1L and Huntington disease: In contrast, treatment with BRD3731 elicited no effects on Drp1-pS616 levels (Supplementary Fig. 7c), further demonstrating that the protective effects of CHIR99021 in HD cells were independent of GSK3 inhibition.